| Reid Stubbee, | |
|
200 Hawkins Dr, Iowa City, IA 52242-1009 | |
| (319) 384-5643 | |
| (319) 356-3900 |
| Full Name | Reid Stubbee |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 200 Hawkins Dr, Iowa City, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578197497 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | R-12174 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Reid Stubbee, 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 384-5643 | Reid Stubbee, 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 384-5643 |
News Archive
Women's heart health has been the focus of a recent study by Monash University, with researchers finding that proportional carbohydrate intake and not saturated fat was significantly associated with cardiovascular disease benefit in Australian women.
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
Cornerstone Pharmaceuticals, Inc. today announced the addition of Mary Crowley Cancer Research Centers to its roster of sites for its ongoing Phase I/II clinical trials of its first-in-class anti-cancer agent, CPI-613. Cornerstone is a leader in the discovery and development of cancer therapies that capitalize upon and disrupt the unique metabolic processes of cancer cells.
The University of Texas MD Anderson Cancer Center and Sanofi today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.
Lifeline Biotechnologies, Inc. today announced that it has completed the updating of the Company's information on Pinks Sheets.
› Verified 5 days ago
Jeffrey Spencer Edman, MD Urology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-5643 Fax: 319-356-3900 | |
James Bradley Mason, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-1616 Fax: 319-356-3900 | |
Charles Haddad Schlaepfer, MD Urology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-5643 | |
Angelena B. Edwards, M.D. Urology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-0748 | |
Dr. Paul Thomas Gellhaus, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, 3327 Rcp, Iowa City, IA 52242 Phone: 319-356-2421 Fax: 319-356-3900 | |
Dr. Elise Foley Myers, MD Urology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-5643 Fax: 319-356-3900 | |
Dr. Kenan B Ashouri, MD Urology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2421 Fax: 319-356-3900 |